Abstract: Solid forms of L-glufosinate materials, including crystalline L-glufosinate ammonium, are described.

Abstract: Solid forms of L-glufosinate materials, including crystalline L-glufosinate ammonium, are described.

Abstract: Solid forms of L-glufosinate materials, including crystalline L-glufosinate ammonium, are described.

Abstract: A wearable electronic device includes an electrode array for transdermal stimulation of a sensory nerve that itself innervates a body part distal to a worn location of the wearable electronic device. The transdermal stimulation is configured to induce an electrical current or voltage that evokes a sensory impression at an area innervated by the sensory nerve, not at the stimulated sensory nerve itself. In one implementation, the wearable electronic device takes a finger ring form factor worn on a proximal phalanx of an index finger. In this configuration, the wearable electronic device can stimulate a portion of a branch of the median nerve extending through the index finger. Upon stimulation of the median nerve, a user wearing the finger ring may perceive pressure applied to the user's fingertip.

Abstract: Compositions and methods for isolating L-glufosinate from a composition comprising L-glufosinate and glutamate are provided. The method comprises converting the glutamate to pyroglutamate followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The composition comprising L-glufosinate and glutamate is subjected to an elevated temperature for a sufficient time to allow for the conversion of glutamate to pyroglutamate, followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The glutamate alternatively may be converted to pyroglutamate by enzymatic conversion. The purified L-glufosinate is present in a final composition at a concentration of 90% or greater of the sum of L-glufosinate, glutamate, and pyroglutamate.

Abstract: A hydroponic growing system is presented. The system can include multiple growing trays in a vertical arrangement, where a pump supplies the top-most tray and each lower tray is supplied by the overlying tray, and where the plumbing elements for supply and drainage are arranged to one side of the system. The system includes variations to support different crop types within the same system, including removable growing structures for root vegetable, microgreens and supports for vining crops. The system can monitor and adjust the nutrients and other features of the systems water profile to concurrently group multiple crops in differing developing stages.

Abstract: Compositions and methods for isolating L-glufosinate from a composition comprising L-glufosinate and glutamate are provided. The method comprises converting the glutamate to pyroglutamate followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The composition comprising L-glufosinate and glutamate is subjected to an elevated temperature for a sufficient time to allow for the conversion of glutamate to pyroglutamate, followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The glutamate alternatively may be converted to pyroglutamate by enzymatic conversion. The purified L-glufosinate is present in a final composition at a concentration of 90% or greater of the sum of L-glufosinate, glutamate, and pyroglutamate.

Abstract: Compositions and methods for isolating L-glufosinate from a composition comprising L-glufosinate and glutamate are provided. The method comprises converting the glutamate to pyroglutamate followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The composition comprising L-glufosinate and glutamate is subjected to an elevated temperature for a sufficient time to allow for the conversion of glutamate to pyroglutamate, followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The glutamate alternatively may be converted to pyroglutamate by enzymatic conversion. The purified L-glufosinate is present in a final composition at a concentration of 90% or greater of the sum of L-glufosinate, glutamate, and pyroglutamate.

Abstract: A hydroponic growing system is presented. The system can include multiple growing trays in a vertical arrangement, where a pump supplies the top-most tray and each lower tray is supplied by the overlying tray, and where the plumbing elements for supply and drainage are arranged to one side of the system. The system includes variations to support different crop types within the same system, including removable growing structures for root vegetable, microgreens and supports for vining crops. The system can monitor and adjust the nutrients and other features of the systems water profile to concurrently group multiple crops in differing developing stages.

Abstract: Compositions and methods for isolating L-glufosinate from a composition comprising L-glufosinate and glutamate are provided. The method comprises converting the glutamate to pyroglutamate followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The composition comprising L-glufosinate and glutamate is subjected to an elevated temperature for a sufficient time to allow for the conversion of glutamate to pyroglutamate, followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The glutamate alternatively may be converted to pyroglutamate by enzymatic conversion. The purified L-glufosinate is present in a final composition at a concentration of 90% or greater of the sum of L-glufosinate, glutamate, and pyroglutamate.

Abstract: A hydroponic growing system is presented. The system can include multiple growing trays in a vertical arrangement, where a pump supplies the top-most tray and each lower tray is supplied by the overlying tray, and where the plumbing elements for supply and drainage are arranged to one side of the system. The system includes variations to support different crop types within the same system, including removable growing structures for root vegetable, microgreens and supports for vining crops. The system can monitor and adjust the nutrients and other features of the systems water profile to concurrently group multiple crops in differing developing stages.

Abstract: A hydroponic growing system is presented. The system can include multiple growing trays in a vertical arrangement, where a pump supplies the top-most tray and each lower tray is supplied by the overlying tray, and where the plumbing elements for supply and drainage are arranged to one side of the system. The system includes variations to support different crop types within the same system, including removable growing structures for root vegetable, microgreens and supports for vining crops. The system can monitor and adjust the nutrients and other features of the systems water profile to concurrently group multiple crops in differing developing stages.

Abstract: A shear web flange (36) for a shear web (32) of a wind turbine blade (18) is described. The flange (36) extends longitudinally and comprises a bonding surface (50) for bonding to an inner surface of a wind turbine blade (18). One or more protruding features (52a, 52b) protrude from the bonding surface (50). A method of making such a shear web flange (36) is also described as are a shear web (32) for a wind turbine blade (18), a wind turbine blade (18) and a method of making a wind turbine blade (18).

Abstract: A hydroponic growing system is presented. The system can include multiple growing trays in a vertical arrangement, where a pump supplies the top-most tray and each lower tray is supplied by the overlying tray, and where the plumbing elements for supply and drainage are arranged to one side of the system. The system includes variations to support different crop types within the same system, including removable growing structures for root vegetable, microgreens and supports for vining crops. The system can monitor and adjust the nutrients and other features of the systems water profile to concurrently group multiple crops in differing developing stages.

Abstract: A hydroponic growing system is presented. The system can include multiple growing trays in a vertical arrangement, where a pump supplies the top-most tray and each lower tray is supplied by the overlying tray, and where the plumbing elements for supply and drainage are arranged to one side of the system. The system includes variations to support different crop types within the same system, including removable growing structures for root vegetable, microgreens and supports for vining crops. The system can monitor and adjust the nutrients and other features of the systems water profile to concurrently group multiple crops in differing developing stages.

Abstract: Compositions and methods for isolating L-glufosinate from a composition comprising L-glufosinate and glutamate are provided. The method comprises converting the glutamate to pyroglutamate followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The composition comprising L-glufosinate and glutamate is subjected to an elevated temperature for a sufficient time to allow for the conversion of glutamate to pyroglutamate, followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The glutamate alternatively may be converted to pyroglutamate by enzymatic conversion. The purified L-glufosinate is present in a final composition at a concentration of 90% or greater of the sum of L-glufosinate, glutamate, and pyroglutamate.

Abstract: A shear web flange (36) for a shear web (32) of a wind turbine blade (18) is described. The flange (36) extends longitudinally and comprises a bonding surface (50) for bonding to an inner surface of a wind turbine blade (18). One or more protruding features (52a, 52b) protrude from the bonding surface (50). A method of making such a shear web flange (36) is also described as are a shear web (32) for a wind turbine blade (18), a wind turbine blade (18) and a method of making a wind turbine blade (18).

Abstract: A medication injection device (2) includes a housing (4) and a needled syringe (8) supported by the housing. The needle syringe has a plunger (10) and a volume containing medication. The medication injection device further includes an expelling mechanism (6) operably coupled to the plunger. Additionally, the device includes a thermal locking mechanism (20) operably coupled to the expelling mechanism, comprising a material which is solid when the device is refrigerated and transitions to a liquid or gel-like state at a phase-change temperature when the device is taken out of refrigeration and warms up together with the contained drug to a temperature which is suitable for performing an injection. In the solid state, the material keeps the expelling mechanism locked in a disabling condition inhibiting delivery of the medication and in its liquid state creates an enabling condition permitting delivery of the medication.

Abstract: 4-Amino-6-(heterocyclic)picolinic acids and their derivatives; 6-amino-2-(heterocyclic)pyrimidine-4-carboxylates and their derivatives; and methods of using the same as herbicides.

Abstract: A medication injection device (2) includes a housing (4) and a needled syringe (8) supported by the housing. The needle syringe has a plunger (10) and a volume containing medication. The medication injection device further includes an expelling mechanism (6) operably coupled to the plunger. Additionally, the device includes a thermal locking mechanism (20) operably coupled to the expelling mechanism, comprising a material which is solid when the device is refrigerated and transitions to a liquid or gel-like state at a phase-change temperature when the device is taken out of refrigeration and warms up together with the contained drug to a temperature which is suitable for performing an injection. In the solid state, the material keeps the expelling mechanism locked in a disabling condition inhibiting delivery of the medication and in its liquid state creates an enabling condition permitting delivery of the medication.